A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
Clinical trial NCT05238701 · COMPLETED
Trial details
- NCT number
- NCT05238701
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-25
- Primary completion
- 2023-11-04
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.